Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.

Works in Cardiovascular · Hematology · Immunology · Metabolic & endocrine · Oncology · Ophthalmology

Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. is a clinical trial sponsor. It has 1 active clinical trial with 45 planned participants, across 6 therapeutic areas. Since 2021 it has completed 0 trials and stopped 1 early.

Trial track record · since 2021

1Active trials45 planned participants
0Completed0 with results posted
1Stopped earlyterminated, withdrawn or suspended

Pipeline · 1 active trial

StageTrialStatus

Questions about Shenzhen MingSight Relin Pharmaceuticals Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-09-29.

Approve Suite is not affiliated with Shenzhen MingSight Relin Pharmaceuticals Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.